ASP Isotopes Inc. (NASDAQ:ASPI – Get Free Report) CFO Heather Kiessling sold 21,830 shares of the firm’s stock in a transaction that occurred on Friday, October 16th. The stock was sold at an average price of $2.19, for a total transaction of $47,807.70. Following the sale, the chief financial officer owned 1,504,422 shares in the company, valued at approximately $3,294,684.18. This trade represents a 1.43% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
ASP Isotopes Price Performance
ASPI stock opened at $2.09 on Friday. The company has a 50 day moving average price of $3.22 and a two-hundred day moving average price of $4.66. The company has a quick ratio of 3.85, a current ratio of 3.87 and a debt-to-equity ratio of 0.76. ASP Isotopes Inc. has a one year low of $1.89 and a one year high of $11.22.
ASP Isotopes (NASDAQ:ASPI – Get Free Report) last issued its quarterly earnings results on Friday, August 14th. The company reported ($0.28) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.17) by ($0.11). ASP Isotopes had a negative return on equity of 64.99% and a negative net margin of 427.98%. The business had revenue of $5.12 million for the quarter, compared to analysts’ expectations of $4.47 million.
Institutional Investors Weigh In On ASP Isotopes
A number of institutional investors have recently bought and sold shares of ASPI. BlackRock Inc. acquired a new position in ASP Isotopes during the second quarter worth approximately $57,331,000. Encompass Capital Advisors LLC purchased a new position in ASP Isotopes during the first quarter worth approximately $30,551,000. AWM Investment Company Inc. acquired a new position in shares of ASP Isotopes in the 2nd quarter valued at $9,837,000. Philadelphia Financial Management of San Francisco LLC acquired a new position in shares of ASP Isotopes in the 2nd quarter valued at $8,353,504. Finally, Man Group plc acquired a new position in shares of ASP Isotopes in the 2nd quarter valued at $5,153,000. 16.80% of the stock is currently owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
Several equities analysts recently commented on ASPI shares. Wall Street Zen upgraded ASP Isotopes from a “strong sell” rating to a “sell” rating in a research note on Saturday, August 22nd. Weiss Ratings reissued a “sell (d-)” rating on shares of ASP Isotopes in a research note on Monday, September 21st. Two research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company has an average rating of “Hold” and an average target price of $13.00.
View Our Latest Stock Analysis on ASPI
About ASP Isotopes
ASP Isotopes Inc is a materials and technology company developing isotope-enrichment processes for use in the medical, semiconductor and nuclear-energy industries. Its primary technology is the Aerodynamic Separation Process, a proprietary method designed to separate isotopes based on differences in molecular mass and aerodynamic behavior.
The company is pursuing the production of enriched isotopes, including materials intended for applications such as semiconductor manufacturing, medical diagnostics and treatment, advanced nuclear fuels, and other industrial and scientific uses.
Read More
- Five stocks we like better than ASP Isotopes
- Is Texas Instruments Setting Up for Its Next Big Breakout?
- Pegasystems’ Q3 Miss Exposed the Problem Standing Between AI and Cash Flow
- Lam Research’s Earnings Beat Wasn’t the Real Story—Its 2027 Outlook Was
- Tesla’s Flying-Car Hype Hits an Earnings Reality Check
Receive News & Ratings for ASP Isotopes Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ASP Isotopes and related companies with MarketBeat.com's FREE daily email newsletter.
